Table 5 Summary of improvements in HRQoL measures in response to etanercept by treatment group

DLQI, mean (SEM)

−8.4^† (0.5)

−10.8^† (0.5)

−9.5^† (0.6)

−11.0^† (0.6)

EQ-5D, mean (SEM)

0.2 (0.0)

0.3* (0.0)

0.2* (0.0)

0.3* (0.0)

WPAI: % activity impairment due to problem, mean (SEM)

−19.1^† (2.3)

−25.1^† (2.3)

−22.1^† (2.2)

−27.3^† (2.3)

WPAI: % impairment while working due to problem, mean (SEM)

−7.5 (2.5)^†

−16.3 (2.6)*^†

−11.8 (2.0)^†

−18.8 (2.0)*^†

WPAI: % overall work impairment due to problem, mean (SEM)

−7.8 (3.3)^†

−15.1 (3.2)^†

−13.5 (2.8)^†

−16.3 (2.8)^†

WPAI: % work time missed due to problem, mean (SEM)

−3.4 (2.6)^†

0.4 (2.5)^†

−6.1 (2.3)^†

0.6 (2.3)*^†

Total FACIT, mean (SEM)

3.2^† (0.7)

4.5^† (0.7)

4.5^† (0.8)

4.3^† (0.8)